 eMEDONLINE EXPERIENCE |
|
|
In a clinical trial for the National Institutes of Health,
patients were very positive about their experience with eMedonline,
finding it to be easy to use and helpful in understanding the
medications they were taking. They felt more confident
about being able to manage their medications and illness.
eMedonline was developed by Leap of Faith Technologies with support
from the National Cancer Institute
for use in clinical trials, and the National Institute on Aging
for use in disease management. |
 |
|
 PHARMACEUTICAL |
- Recover product revenues lost due to noncompliance
- Lower costs in clinical trials: more efficient data
collection, better data, better adherence
- Manage adverse events and maintain dose intensity in trials
- Greater speed to market with new drugs through more efficient trials
- Extend effective patient life
- Produce data-based label claims
- Protect position in formularies
- Facilitate FDA post-marketing commitment (PMC) Compliance
- Mitigate risk through collection of Phase IV surveillance data
|
|
 SPECIALTY PHARMACY |
- Improve patient safety and operational efficiency
- Simplify and reduce the time necessary for patient education
- Reduce potential errors in dosing and product waste
- Reduce the overall cost of treatment
- Increase sales through higher refill rates
- Leverage existing operations and infrastructure
- Provide service differentiation
- A complete therapeutic solution
|
|
 DISEASE MANAGEMENT |
- Manage adverse events and reduce healthcare costs
- Increase patient compliance with prescribed therapy
- Educate patients on the proper use of medications
- Reduce the time necessary to educate the patient regarding treatment
- Improve patient safety and operational efficiency
- Reduce potential errors in dosing and the overall cost of treatment
- Leverage existing operations and infrastructure
- A complete therapeutic solution
|
|
